• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » addiction-treatment

Articles Tagged with ''addiction-treatment''

New Generic Versions of Naloxone

August 1, 2019
Talia Puzantian, PharmD, BCPP.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Talia Puzantian, PharmD, BCPP. Dr. Puzantian has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Naloxone, a rescue medication effective for reversing opioid overdose, will soon be available in two generic forms for layperson use. This news of note summarizes these generic, lower-cost products.
Read More

Opioid Use Disorder: Is There an App for That?

August 1, 2019
Joshua Sonkiss, MD.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Joshua Sonkiss, MD. Dr. Sonkiss has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This News of Note discusses the first FDA-approved mobile app for SUDs, called reSET-O. Classified as a mobile medical app (MMAs), reSET-O can be used as an adjunct to outpatient opioid use disorder treatment. Unlike most apps, reSET-O requires a prescription to unlock and use.
Read More

Gabapentin Enacarbil XR Efficacy Less Than Expected for AUD

August 1, 2019
Thomas Jordan, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Thomas Jordan, MD Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This 2019 randomized, double-blind, placebo- controlled trial study casts doubt on using gabapentin enacarbil extended-release (GE-XR) (Horizant), an extended-release version of gabapentin, for treatment in patients with alcohol use disorder
Read More

Can Buprenorphine Improve PTSD Symptoms?

August 1, 2019
Thomas Jordan, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Thomas Jordan, MD Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This 2019 retrospective study examines the potential benefits of using buprenorphine/naloxone to treat co-occurring PTSD and opioid use disorder.
Read More

Helping Patients Maintain Recovery

July 2, 2019
Excerpted from a past issue of The Carlat Addiction Treatment Report, Matthew Goldenberg, DO, Founder of Professionals Health Solutions and assistant professor of psychiatry at Cedars-Sinai Medical Center, offers the following advice:Enhance your patients’ courage. Many people with SUDs may not think of themselves as brave, but it takes guts...
Read More

Tips for Better Motivational Interviewing

June 27, 2019
In The Carlat Addiction Treatment Report, David Rosengren, PhD, President of the Prevention Research Institute, gives the following tips on how to conduct motivational interviewing:Be curious, not an expert.Training and expertise can get in the way of our really hearing the client’s story. For example, a client says, “I don’t...
Read More

Strategies for Getting Patients to Quit Smoking

June 21, 2019
For patients who smoke intermittently, you should start with nicotine replacement therapies, such as nicotine lozenges or gum, which can be used on a PRN basis.Patients who smoke more frequently, such as several times per day, will need consistent nicotine replacement from a patch to prevent the peaks and troughs...
Read More

Safe Use of Gabapentin with Patients

June 19, 2019
Although there’s been a lot of discussion about gabapentin’s abuse potential, gabapentin substance use disorders are pretty rare, with one study finding that only 2% of 44,148 patients using gabapentin alone met criteria for sustained overuse (Peckham et al, Pharmacotherapy, in press). The one area where you should show caution,...
Read More

Co-Occurring Addiction and PTSD

May 21, 2019
Dolores Vojvoda, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Dolores Vojvoda, MD Dolores Vojvoda, MD
Assistant Professor of Psychiatry, Yale School of Medicine

Dr. Vojvoda has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Individuals who have PTSD have a high risk of developing other disorders, including substance use disorders (SUDs). Studies have shown that both in the veteran and non-veteran populations, these numbers are high.
Read More

Oral vs Extended-Release Naltrexone for Opioid Use Disorder

May 21, 2019
Jessica Goren, PharmD.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Jessica Goren, PharmD. Dr. Goren has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Extended-release (XR) naltrexone (Vivitrol) is FDA approved for opioid use disorder and has shown efficacy in several trials. It works best for patients who have already successfully detoxed from opioids and who are highly motivated to abstain. But what about oral naltrexone?
Read More
Previous 1 2 3 4 5 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.